Reversing dabigatran effect with idarucizumab to enable intravenous thrombolysis in patients with acute ischaemic stroke - a single centre experience
CONCLUSIONS AND CLINICAL IMPLICATIONS: Our study results are in line with previous research on this topic, showing that IVT after idarucizumab can be successfully administered and is reasonably safe in dabigatran-treated patients with AIS.PMID:37955597 | DOI:10.5603/pjnns.96469
Source: Neurologia i Neurochirurgia Polska - Category: Neurology Authors: Ewa W łodarczyk Katarzyna Sawczy ńska Pawe ł Wrona Agnieszka S łowik Source Type: research
More News: Atrial Fibrillation | Brain | Hemorrhagic Stroke | Ischemic Stroke | Neurology | Poland Health | Pradaxa | Stroke | Study